StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.44+0.03 (+2.13%)

Close on Nov 18, 2026Market cap $14.32MP/E –Yield –

Seres Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Seres Therapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 0.4× to 65.8×, with a median of 5.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−2.6
2025Dec 31, 20253.0×−2.9
2024Dec 31, 20245.9×−2.7
2023Oct 31, 20238.7×−1.6
2022Dec 30, 202210.3×+6.0
2021Dec 31, 20214.4×−7.5
2020Dec 31, 202011.9×−18.8
2018Jul 31, 201830.7×+25.9
2017Dec 29, 20174.8×+2.2
2016Dec 30, 20162.6×−3.6
2015Dec 31, 20156.2×–

More Seres Therapeutics figures

See a number that looks wrong?